SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
267 hedge funds and large institutions have $8.95B invested in Sage Therapeutics in 2019 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 132 increasing their positions, 59 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
57% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 35
8% more funds holding
Funds holding: 248 → 267 (+19)
4.41% more ownership
Funds ownership: 106.12% → 110.53% (+4.4%)
Holders
267
Holding in Top 10
10
Calls
$177M
Puts
$98.9M
Top Buyers
| 1 | +$240M | |
| 2 | +$216M | |
| 3 | +$91.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$86.4M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$78.8M |
Top Sellers
| 1 | -$58.7M | |
| 2 | -$53.5M | |
| 3 | -$30.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$20.8M |